Valuation Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 22/04/2026 am IST			5-day change	1st Jan Change
96.22 ^USD	-0.72%		-1.50%	-2.58%

22/04	Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing	MT
21/04	Incyte Highlights New Phase 3 Tafasitamab Data At the 2026 American Society of Clinical Oncology Annual Meeting	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	16,213	17,869	14,072	13,306	19,391	19,149	-	-
Change	-	10.21%	-21.25%	-5.44%	45.73%	-1.25%	-	-
Enterprise Value (EV) ¹	13,865	14,630	10,416	11,148	16,293	13,968	12,296	10,494
Change	-	5.52%	-28.81%	7.03%	46.15%	-14.27%	-11.96%	-14.66%
P/E ratio	17.2x	52.8x	23.7x	460x	15.4x	15.5x	13.1x	12.2x
PBR	4.32x	4.09x	2.71x	3.88x	3.79x	2.87x	2.25x	1.82x
PEG	-	-0.8x	0.3x	-4.9x	0x	-4.9x	0.7x	1.66x
Capitalization / Revenue	5.43x	5.26x	3.81x	3.14x	3.77x	3.44x	3.1x	2.96x
EV / Revenue	4.64x	4.31x	2.82x	2.63x	3.17x	2.51x	1.99x	1.62x
EV / EBITDA	21.5x	24.5x	14.8x	22.2x	9.53x	7.89x	5.93x	5.23x
EV / EBIT	23.7x	25.2x	16.8x	26.9x	10.1x	7.52x	5.23x	4.01x
EV / FCF	24.4x	16.4x	22.4x	44.8x	-	10.5x	8.38x	6.47x
FCF Yield	4.1%	6.1%	4.45%	2.23%	-	9.49%	11.9%	15.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.27	1.52	2.65	0.15	6.41	6.207	7.326	7.863
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,986	3,395	3,696	4,241	5,141	5,574	6,183	6,463
EBITDA ¹	643.6	597.7	703.2	503.1	1,709	1,769	2,073	2,007
EBIT ¹	585.8	579.4	620.5	413.9	1,616	1,856	2,350	2,617
Net income ¹	948.6	340.7	597.6	32.62	1,287	1,281	1,527	1,654
Net Debt ¹	-2,348	-3,239	-3,656	-2,158	-3,098	-5,182	-6,853	-8,655
Reference price ²	73.40	80.32	62.79	69.07	98.77	96.22	96.22	96.22
Nbr of stocks (in thousands)	2,20,891	2,22,475	2,24,109	1,92,650	1,96,323	1,99,014	-	-
Announcement Date	08/02/22	07/02/23	13/02/24	10/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INCYTE CORPORATION	15.61x	2.53x	7.97x	-.--%	1.93TCr
REGENERON PHARMACEUTICALS, INC.	19.24x	4.38x	13.16x	0.52%	7.69TCr
UCB	28.28x	5.65x	16.29x	0.56%	5.81TCr
SAMSUNG BIOLOGICS CO.,LTD.	39.08x	13.17x	24.11x	-.--%	5.06TCr
CSL LIMITED	35.78x	3.56x	10.31x	2.98%	4.73TCr
BIOGEN INC.	15.4x	2.9x	8.69x	-.--%	2.69TCr
MODERNA, INC.	-7.54x	8.52x	-6.27x	-.--%	2.16TCr
SWEDISH ORPHAN BIOVITRUM AB	24.77x	5.01x	13.66x	-.--%	1.58TCr
BRIDGEBIO PHARMA, INC.	-39.34x	17.73x	-49.48x	-.--%	1.49TCr
ALTEOGEN INC.	74.54x	38.35x	52.11x	0.09%	1.35TCr
Average	20.58x	10.18x	9.05x	0.42%	3.45TCr
Weighted average by Cap.	23.65x	7.75x	11.89x	0.62%